Name |
Herkunft |
Vortragstitel |
Datum |
Prof. Dr. Ian McGregor |
Psychopharmacology University of Sydney, Australia |
Prosocial effects of novel non-peptide oxytocin ligands in models of social stress |
25.07.2011 |
Prof. Dr. Laszlo Horvath |
Division of Cellbiology, Linköping, Sweden |
Knockdown of GAD67 in a rodent model of Parkinson’s disease |
13.07.2011 |
Dr. Michael Bowen |
Psychopharmacology University of Sydney, Australia |
Predator odour induces huddling in rats: a stress response that is exacerbated by alcohol and is associated with lower levels of depression and anxiety like behaviours |
12.07.2011 |
Prof. Dr. Bernhard Bettler |
Physiology, Basel, Switzerland |
GABA-B receptors: from structure to synaptic physiology and mental disorders |
07.07.2011 |
Prof. Dr. Cort A Pedersen |
Psychiatry Univ. of North Carolina at Chapel Hill, USA |
Clinical applications of oxytocin: Relationships to the evolution of social bonds |
06.06.2011 |
Dr. Susanne Brummelte |
University of British Columbia, Vancouver, Canada |
Stress, depression and pain during development: How early experiences shape our brain and behaviour? |
26.05.2011 |
Prof. Dr. Andrea Sgoifo |
Dept. of Evolutionary & Functional Biology, University pf Parma, Italy |
Physiology and pathophysiology
of social stress |
15.11.2010 |
Prof. Dr. Martin Schalling |
Karonlinska Institute, Stockholm, Sweden |
Genetics of fear, anxiety and affective disorders |
27.09.2010 |
Prof. Dr. Bice Chini |
University of Milan, Italy |
Oxytocin receptor coupling to different G-proteins in neuronal cells |
14.05.2010 |
Prof. Dr. Klaus Miczek |
Tufts University, Massachusetts, USA |
Social stress, brain dopamine and BDNF: Implications for cocaine abuse and depression |
10.05.2010 |
Dr. Christine Heim |
Emory University, Atlanta, USA |
The contribution of early adverse experience to the neurobiology of depression |
16.03.2010 |
PD Dr. Karl Ebner |
Center for Molecular Biosciences Innsbruck, University of Innsbruck, Australia |
Substance P in Stress and Anxiety |
21.12.2009 |
Dr. Greg Wegener |
Aarhus University Hospital, Risskov, Denmark |
Neuropeptide actions in health & disease |
14.12.2009 |
Prof. Dr. Carmen Sandi |
Brain Mind Institute, Lausanne, Switzerland |
Violence and socialinequity generated by stress |
10.12.2009 |
Dr. Fabrizio Gasparini |
Novartis Pharma AG, Switzerland |
mGluR5 non-competitive Antagonists: Identification, Characterization and Clinical Development in the fields of Anxiety, Pain and Parkinson's Disease |
16.11.2009 |
Dr. Trynke de Jong |
University of California, USA |
Brain neuromodulators of social behaviour: paternal & sexual behaviour |
29.09.2009 |
Prof. Dr. Maurizio Popoli |
Center of Neuropharmacology, University of Milano, Italy |
New perspectives and strategies in research on pathophysiology of depression and therapeutic drug mechanisms |
04.12.2008 |
Prof. Dr. Ron Stoop |
Cellular Neuroendocrinology, University of Lausanne, Switzerland |
Stress-regulation by neuropeptides on neuronal level |
30.10.2008 |
Dr. Erwin van den Burg |
Dept. Of Psychiatry, Hospital de Cery, Prilly, Switzerland |
Dissecting stress and fear circuits: from evolutionary conservation to individual, gender-dependent differences |
20.08.2008 |
Prof. Dr. Alexander A. Mathé |
Karolinska Institute, Clinical Neuroscience, Stockholm, Sweden |
Effects of early life events on adult brain and behaviour: gender-dependent effects |
09.06.2008 |
Prof. Dr. Gregers Wegener |
University of Aarhus, Dänemark |
Gender differences in emotional responses and susceptibility to stress |
06.03.2008 |
Dr. Isabel Pineau |
McGill University, Montreal, Kanada |
Gender differences in the role of inflammatory cytokines in the nervous system |
04.03.2008 |
WCNH Symposium |
|
|
|
Dr. Heon-Jin Lee |
Bethesda, USA |
Behavioural studies using temporal and spatial inactivation of the oxytocin receptor |
19.09.2007 |
Dr. Yevgenia Kozorovitskiy |
Princeton, USA |
Experience-dependent plasticity in the father's brain |
19.09.2007 |
Prof. Dr. Richard Ebstein |
Jerusalem, Israel |
The role of arginine vasopressin 1a and oxytocin receptor polymorphisms in moderating social behaviour in humans |
19.09.2007 |
Prof. Dr. Gerald Heckel |
Bern, Switzerland |
Evolution of vasopressin receptor genes and mammalian behaviour |
19.09.2007 |
Prof. Dr. Markus Heinrichs |
Zürich, Switzerland |
Neuropeptides, anxiety and social behaviour: effects of oxytocin and vasopressin in humans |
19.09.2007 |
Prof. Dr. Eric Hollander |
New York, USA |
Intravenous and intranasal oxytocin targets social cognition and repetitive behaviour domains in autism: behavioural and functional imaging findings |
19.09.2007 |
Dr. Heather Caldwell |
Bethesda, USA |
The role of the vasopressin 1b receptor in aggression and other social behaviours |
19.09.2007 |
Prof. Dr. James Goodson |
Indiana University Bloomington, USA |
Nonapeptides and the evolutionary patterning of sociality |
19.09.2007 |
Prof. Dr. Kazuhito Tomizawa |
Okayama University, Japan |
1) Regulation of behavioral and
neuroendocrine stress responses
by brain oxytocin
2) Methods in Molecular Neuroendocrinology |
13.02.2007
12.02.2007 |
Prof. Dr. Dionysia Theodosis |
University of Bordeaux |
Oxytocin-induced plasticity in the
maternal brain |
08.06.2006 |
Dr. Simone Sartori |
Universität Innsbruck |
1) Neurochemical characterization of
rats selectively bred for differences
in emotionality
2) Brain neurochemistry:
methodological aspects |
20.11. 2006 |
Dr. Luz Torner |
IMSS/Biomedical Research Center, Mexico |
1) Prolactin effects in the brain in
Context of stress & neurogenesis
2) Neuropeptide signaling in the
hypothalamus: technical advances |
30.11.2006
07.12.2006 |
